Stay updated on DS-8201a in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the DS-8201a in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DS-8201a in HER2+ Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4 on the page. This represents a small software/format update rather than any substantive change to the study text or data.
    Difference
    0.0%
    Check dated 2026-05-19T09:45:59.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    A new revision tag 'Revision: v3.5.3' was added and the previous 'Revision: v3.5.2' was removed, signaling a small update to the page.
    Difference
    0.0%
    Check dated 2026-04-27T19:42:37.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-20T16:28:11.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Padua, Italy 35128 was updated to Padova, Italy 35128 in the locations list.
    Difference
    0.0%
    Check dated 2026-04-06T03:16:46.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Added Naples, Italy, 80131 as a study location and removed Napoli, Italy, 80131; page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T22:09:35.000Z thumbnail image
  9. Check
    90 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-08T13:45:44.000Z thumbnail image

Stay in the know with updates to DS-8201a in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DS-8201a in HER2+ Breast Cancer Clinical Trial page.